Zhang, J., Zhang, R., Tsao, S., Liu, Y., Chen, X., Lu, D., . . . Chang, L. (2018). Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient. Blood Adv.
Chicago-stil citatZhang, Jian-Ping, Rui Zhang, Shih-Ting Tsao, Yu-Chen Liu, Xiaochuan Chen, Dao-Pei Lu, Paul Castillo, och Lung-Ji Chang. "Sequential Allogeneic and Autologous CAR-T–cell Therapy to Treat an Immune-compromised Leukemic Patient." Blood Adv 2018.
MLA-referensZhang, Jian-Ping, et al. "Sequential Allogeneic and Autologous CAR-T–cell Therapy to Treat an Immune-compromised Leukemic Patient." Blood Adv 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.